CLPT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

Stats
Today's Volume	55 009.00
Average Volume	152 448
Market Cap	148.37M
EPS	$0 ( 2024-03-12 )
Next earnings date	( $-0.190 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.11
ATR14	$0.0250 (0.45%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Fletcher R John	Buy	850	Common Stock
2024-04-01	Girin Pascal E R	Buy	1 056	Common Stock
2024-04-01	Liau Linda M.	Buy	436	Common Stock
2024-04-01	Richards Timothy T.	Buy	1 640	Common Stock
2024-03-11	Stigall L. Jeremy	Buy	16 583	Restricted Stock Units

INSIDER POWER
55.26
Last 96 transactions
Buy: 810 905 \| Sell: 147 333

Volume Correlation

Long: 0.02 (neutral)

Short: 0.99 (very strong)

Signal:(52.322) Expect same movement, but be aware

Clearpoint Neuro Inc Correlation

10 Most Positive Correlations
XEL	0.889
AMGN	0.874
RMRM	0.856
LMST	0.848
AEPPZ	0.845
CPRX	0.832
KPTI	0.832
DRVN	0.83
LOPE	0.824
ASO	0.823

10 Most Negative Correlations
ENTG	-0.849
VECO	-0.846
AURA	-0.826
PLUS	-0.819
PSMT	-0.814
SVRA	-0.813
JCOM	-0.81
AMRB	-0.805
PSEC	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Clearpoint Neuro Inc Correlation - Currency/Commodity

-0.07
( neutral )

-0.04
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.20
( neutral )

-0.10
( neutral )

Clearpoint Neuro Inc Financials

Annual	2023
Revenue:	$23.96M
Gross Profit:	$13.61M (56.83 %)
EPS:	$-0.900

Q4	2023
Revenue:	$6.81M
Gross Profit:	$4.01M (58.93 %)
EPS:	$-0.190

Q3	2023
Revenue:	$5.76M
Gross Profit:	$3.27M (56.80 %)
EPS:	$-0.200

Q2	2023
Revenue:	$5.95M
Gross Profit:	$3.13M (52.54 %)
EPS:	$-0.290

Financial Reports:

No articles found.

Clearpoint Neuro Inc

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.